Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II01:27

Pneumothorax-II

852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case of Schöpf-Schulz-Passarge syndrome presented with widespread apocrine hidrocystomas showing variable clinical features.

Acta dermatovenerologica Croatica : ADC·2026
Same author

Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Neuromuscular Electrical Stimulation in Brachial Plexus Birth Injury Rehabilitation: A Systematic Review.

Medicina (Kaunas, Lithuania)·2026
Same author

Klinische Padiatrie·2026
Same author

Down Syndrome: From Pregnancy through Childhood in Türkiye.

Molecular syndromology·2026
Same author

Glutathione peroxidase 2 expression in human tumors: a tissue microarray study on 18,555 tumors.

Frontiers in oncology·2026

Related Experiment Video

Updated: Jan 8, 2026

Pulmonary Embolism III: Nursing Management
01:27

Pulmonary Embolism III: Nursing Management

Published on: June 19, 2025

320

Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function.

Ender Karaca1, Stefan Weitzer2, Davut Pehlivan1

  • 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.

Cell
|April 29, 2014
PubMed
Summary

Mutations in the CLP1 gene, crucial for RNA processing, cause a severe neurological disorder affecting motor function and brain development. This highlights the role of rare genetic variations in human disease.

More Related Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Published on: June 19, 2025

277
Pulmonary Embolism I: Introduction
01:29

Pulmonary Embolism I: Introduction

Published on: June 19, 2025

464

Related Experiment Videos

Last Updated: Jan 8, 2026

Pulmonary Embolism III: Nursing Management
01:27

Pulmonary Embolism III: Nursing Management

Published on: June 19, 2025

320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Published on: June 19, 2025

277
Pulmonary Embolism I: Introduction
01:29

Pulmonary Embolism I: Introduction

Published on: June 19, 2025

464

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • CLP1 (CASEIN LYSINE RICH PROTEIN 1) is an RNA kinase essential for tRNA splicing.
  • Kinase-dead CLP1 in mice leads to neuromuscular disorders, including motor neuron loss and paralysis.
  • CLP1's role in neurological development is increasingly recognized.

Purpose of the Study:

  • To investigate the role of CLP1 mutations in human neurological disorders.
  • To elucidate the molecular mechanisms underlying CLP1-associated neurological phenotypes.
  • To explore the significance of rare genetic variations in disease etiology.

Main Methods:

  • Human genome analysis to identify CLP1 mutations in affected families.
  • Biochemical assays to assess CLP1 interaction with the TSEN complex and pre-tRNA cleavage activity.
  • Phenotypic analysis of affected individuals and CLP1 kinase-dead mouse models.

Main Results:

  • A homozygous CLP1 missense mutation (p.R140H) was identified in five families, causing loss of interaction with the TSEN complex.
  • Mutations led to reduced pre-tRNA cleavage, accumulation of linear tRNA introns, and severe motor-sensory defects.
  • Affected individuals and mice exhibited microcephaly and cortical dysgenesis due to enhanced neuronal progenitor cell death.

Conclusions:

  • CLP1 mutations impair tRNA splicing, leading to a distinct neurological syndrome.
  • The study highlights the critical role of CLP1 in neuronal development and brain formation.
  • This research underscores the importance of rare genetic variations and supports the clan genomics hypothesis.